
EuroAPI
EAPI | PA
Overview
Corporate Details
- ISIN(s):
- FR0014008VX5 (+2 more)
- LEI:
- 9695002FT7GGI3CKKJ14
- Country:
- France
- Address:
- 15 RUE TRAVERSIERE, 75012 PARIS
- Website:
- https://www.euroapi.com/en
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO).
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-30 17:58 |
Regulatory News Service
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de …
|
French | 531.0 KB | |
2025-06-30 17:58 |
Regulatory News Service
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 trans…
|
English | 704.7 KB | |
2025-06-17 17:02 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
|
French | 124.2 KB | |
2025-06-17 16:46 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
|
French | 104.6 KB | |
2025-06-04 17:45 |
Board/Management Change
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Sol…
|
English | 704.4 KB | |
2025-06-04 17:45 |
Board/Management Change
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des ac…
|
French | 529.1 KB | |
2025-05-21 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Assemblée Générale Mixte du 21 mai 2025
|
French | 522.9 KB | |
2025-05-21 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Combined General Meeting of May 21, 2025
|
English | 722.2 KB | |
2025-04-29 17:40 |
General Meeting Notice
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de…
|
French | 500.7 KB | |
2025-04-29 17:40 |
General Meeting Notice
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
|
English | 618.8 KB | |
2025-04-29 00:00 |
General Meeting Notice
Communiqué de mise à disposition des documents préparatoires relatifs à l'Assem…
|
French | 500.7 KB | |
2025-04-01 17:39 |
Report Publication Announcement
Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Ra…
|
French | 441.8 KB | |
2025-04-01 17:39 |
Report Publication Announcement
Availability of the 2024 Universal Registration Document, including the Annual …
|
English | 438.0 KB | |
2025-04-01 12:11 |
Annual Report (ESEF)
Universal Registration Document 2024
|
English | 89.9 MB | |
2025-03-10 15:29 |
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuil
|
French | 218.5 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
Antibiotice S.A. | Romania | ATB |